Sign in

CIK 0001175680

  • Non-accelerated filer
  • Smaller reporting company

CytoDyn Inc.

Sign in to watch
Ticker
CYDY
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
May 31
Incorporated
DE
Entity type
Operating
EIN
753056237
Phone
+1 360-980-8524
Business address
1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
Former names
CYTODYN INC, REXRAY CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2010-09-15 ALLEN CORINNE E Chief Financial Officer Gift −81,000 1,038,071
2010-01-15 Van Ness Kenneth CEO & President Sale −300 $1.93 $579 1,929,041
2010-01-13 Dembow George F Director Grant or award · Options (right to acquire) +50,000 50,000
2010-01-13 TROPP RONALD J Director Grant or award · Options (right to acquire) +100,000 100,000
2010-01-13 Naydenov Jordan G Director Purchase · Series B Convertible Preferred Stock +20,000 $5.00 $100K 60,000
2010-01-13 Naydenov Jordan G Director Grant or award · Options (right to buy) +75,000 75,000
2010-01-13 GOULD GREGORY A Director Grant or award · Options (right to acquire) +125,000 125,000
2010-01-11 Van Ness Kenneth CEO & President Sale −5,000 $1.95 $10K 1,929,341
2010-01-06 Van Ness Kenneth CEO & President Sale −4,242 $1.80 $8K 1,934,341
2010-01-05 Van Ness Kenneth CEO & President Sale −1,400 $1.78 $2K 1,938,583
2010-01-04 Van Ness Kenneth CEO & President Sale −5,000 $1.75 $9K 1,939,983
2009-12-29 Van Ness Kenneth CEO & President Sale −2,557 $1.69 $4K 1,944,983
2009-12-22 Van Ness Kenneth CEO & President Sale −500 $1.66 $830 1,947,540
2009-11-13 ALLEN ALLEN D Chief Executive Officer Sale −300,000 $0.50 $150K 1,403,515
2009-10-26 Van Ness Kenneth CEO & President Sale −7,000 $1.32 $9K 1,948,040
2009-10-23 Van Ness Kenneth CEO & President Sale −6,535 $1.13 $7K 1,955,040
2009-10-22 Van Ness Kenneth CEO & President Sale −2,805 $1.10 $3K 1,961,575
2009-10-19 Van Ness Kenneth CEO & President Sale −1,739 $1.08 $2K 1,964,380
2009-10-16 Van Ness Kenneth CEO & President Sale −18,940 $1.02 $19K 1,966,119
2009-10-07 Dembow George F Director Purchase · Series B Convertible Preferred Stock +5,000 $5.00 $25K 5,000

Page 45 of 48 · 951 trades